VASTU VIHAR BIOTECH PVT.

LTD

Vastu Vihar Biotech: On Disease, Parkinson Disease,

the Verge of Creating New Chronic Kidney Disease etc. are
the most common ones. Vastu
Age Therapeutic Solutions
Vihar Biotech, committed
for Autoimmune Diseases
towards finding a novel cure for
Using exRNA
autoimmune diseases, believes,
the exRNA based drug therapy
The growing prevalence of could lead the way to a reliable,
autoimmune diseases is non-toxic, long lasting and cost-
becoming a challenge for the effective treatment for the
healthcare industries all over the incurable, complex and globally
world. Autoimmune diseases, are prevalent autoimmune diseases,
considered to be the third most that are generally lifelong and is
common cause of chronic illness, a result of an overactive immune
especially in the United States. system that mistakenly starts
On the other hand nearly 4% of killing the healthy cells, ultimately
the world’s population is found to leading to several other
be effected by one or the other complexities of the body.
type of autoimmune diseases, of
which Diabetes type-1, Psoriasis,
Rheumatoid Arthritis, Multiple
“Our intervention is based
Sclerosis, Asthma, Chronic on a drug molecule that is
Obstructive Pulmonary Disorder actually an exRNA”
(COPD), Polycystic Ovary
Syndrome (PCOS), Alzheimer’s
The Initiation exRNA having an anti-
inflammatory as well as immune
Vastu Vihar Biotech, founded in
suppressant competence.
2014, by CMD Mr, Vinay Kumar
Tiwary, is based in Bodhgaya, The Roadmap
Bihar. The company is an
The company led by Mr. Tiwary,
emerging drug development
with its continuous in-depth
company focusing on ribozyme
research and various
technology to accelerate the
experiments, now is in the
discovery of novel therapeutic
process of IND (Investigational
solutions for the benefit of
new drug) for the treatment of
patients and healthcare
Psoriasis, which is a persistent
providers. Realizing, the existing
as well as relapsing inflammatory
solutions are short-term and fails
skin disease that usually occurs
to target the root cause of the
due to the autoimmune hyper
disease, the company has been
response and strong genetic
focusing on the mechanism in
predisposition.
which, targeting and
Another drug ‘VV Psoriasis
downregulation of responsible
Spray’ is in the process of
gene, cytokines and chemokines
approval by the ‘Ministry of
or the pathways involved in the
Ayush’ under the category of
development of the disease is
Ayurvedic medicine for the
prioritized.
treatment of Psoriasis. Evidently,
Vastu Vihar Biotech, unlike the
till date there are inadequate,
existing solutions does not aim to
and in-efficient treatment
provide temporary solutions,
strategies relying on the
rather it is working towards the
reduction of the symptoms only.
development of a drug molecule,
On the other hand, the drug
namely exRP250, which is an
formulated by Vastu Vihar
biotech, containing herbal
extracts, not only reduces the
symptoms associated with
psoriasis but, also cure the
disease by down-regulating the
responsible cytokines such as IL-
17, IL-23, IL-22, IL-1 β, IL-6,
IFNϒ, and TNFα.

“Our vision is to become one of

the leading contributors to the
service of mankind. We are
devoting all our time and
resources, finding ways to help
combat some of the deadly
diseases that have been
challenging our existence for a
long time”, concludes Mr. Tiwary.